This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Print page

Life Sciences

Clear advice in an uncertain world

The global life sciences industry continues to face periods of uncertainty, with mounting pressures experienced across the sector.

We look at issues such as increased regulation, dialogue on personalised healthcare programmes, the ubiquitous need to innovate and pricing pressures on an already challenged industry by those that end up paying the bill. 

In addition, the UK industry is having to tackle mounting challenges and competition from around the world as countries like India emerge. Our industry specialists from across Deloitte provide an extensive depth of knowledge on the range of current issues experienced by the pharmaceuticals, biotechnology, medical device and private healthcare industries.  

MORE Research and insight

  • Measuring the return from Pharmaceutical innovation 2012
    Measuring the return from Pharmaceutical innovation 2012
    This Deloitte report is the third in an annual series exploring the pharmaceutical industry’s performance in generating a return from its investment in new product innovation.
  • Telecare and Telehealth
    'Telecare and Telehealth - A game changer for health and social care’ looks at the role that telecare and telehealth can play in helping to transform health and social care by enabling commissioners and providers to respond effectively to rising demand for health and social care services.
  • 2011 Survey of Health Care Consumers in UK
    2011 Survey of Health Care Consumers in UK
    This is the second consecutive year Deloitte has published research on consumers' behaviors, attitudes and unmet needs based on their personal experiences and observations of the UK health care systems. View all country reports.
  • Measuring the return from innovation
    Measuring the return from innovation
    Last year Deloitte and Thomson Reuters conducted an analysis into value measurement at the "whole R&D business" level using Internal Rate of Return (IRR). This year, we have extended our analysis, looking at the same cohort of companies one year on.
  • Are you agile enough?
    Winning in Life Sciences Are you agile enough?
    Winning in Life Science brochure “Are you agile enough?” is the second iteration of a series which highlights Deloitte’s key propositions to the Life Science and Healthcare industries many and varied challenges.

Useful links

  • In the press
  • Careers
  • Submit a request for proposal

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options
Follow:

           Deloitte Blog

© 2013 Deloitte LLP. All rights reserved. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity.

Please see About Deloitte for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its Member Firms. View our accessibility statement.

Get in touch

More on Deloitte

Highlights